Express Scripts Makes 'Fundamental Changes' In FTC Deal

By Bryan Koenig

Express Scripts on Wednesday agreed to what the Federal Trade Commission called a "landmark settlement" promising major changes to its drug formulary practices, allowing the company to duck out of a case accusing all three of the country's largest pharmacy benefit managers of inflating insulin prices through rebate schemes.

2 documents attached | Read full article » | Save to favorites »

'Careless Or Disingenuous': Judge Rips CareFirst Rethink Bid

By Hailey Konnath

A Virginia federal judge Wednesday refused to reconsider an order reversing course and throwing out key claims in CareFirst's suit against Johnson & Johnson over the immunosuppressive drug Stelara, calling CareFirst's arguments for doing so "either careless or disingenuous."

Order attached | Read full article » | Save to favorites »

Teva Wins 1st Paragard IUD Bellwether Trial

By Kelcey Caulder

Teva Pharmaceuticals won a complete defense verdict Tuesday in the first trial testing claims that the company failed to warn consumers that its Paragard IUD has a defect making it prone to breakage inside patients' uteri.

2 documents attached | Read full article » | Save to favorites »

Fed. Circ. Leans Toward Vacating $12.7M Copyright Award

By Madeline Lyskawa

The Federal Circuit appeared likely to vacate a $12.7 million copyright infringement award against the federal government on Wednesday, pressing attorneys for a software developer and the government to answer what instructions should be given to the claims court on remand.

Read full article » | Save to favorites »

Drugmaker Claims Stake In La. Mail-Order Abortion Meds Row

By Mark Payne

An abortion medication manufacturer asserted its right Wednesday to defend mifepristone, moving to intervene in a federal lawsuit over mail-order abortion medication brought by Louisiana alleging that regulators violated federal law by removing an in-person dispensing requirement for the drug.

Motion attached | Read full article » | Save to favorites »

Medtronic Owes $381M For Antitrust 'War Games,' Jury Told

By Craig Clough

An attorney for Applied Medical told a California federal jury Wednesday during closing arguments in an antitrust trial against Medtronic that internal documents from the medical device giant show it played illegal "war games" against his client and should pay up to $381 million. 

Read full article » | Save to favorites »

Law360 Seeks Members For Its 2026 Editorial Boards

Law360 is looking for avid readers of our publications to serve as members of our 2026 editorial advisory boards.

2 documents attached | Read full article » | Save to favorites »

Whoop Nabs Block On Chinese Co.'s Health-Tracker Products

By Elliot Weld

A Massachusetts federal judge has blocked a Chinese company from selling in the U.S. its health-tracking products that were alleged by health band maker Whoop Inc. to be infringing its trade dress.

2 documents attached | Read full article » | Save to favorites »

Class Attys In Del. Northwest Biotherapeutics Praise Deal

By Jeff Montgomery

Delaware Chancery Court has lined up a March 16 settlement hearing for a four-year stockholder lawsuit alleging insiders of Northwest Biotherapeutics Inc. received $40 million in stock awards, with proposals including a call for the company to forfeit nearly 22.9 million stock options and it receiving $2.25 million.

Brief attached | Read full article » | Save to favorites »

Drugmakers Say Hagens Berman Responsible For Costs

By Emma Cueto

Drugmakers including GSK and Sanofi have told a Pennsylvania federal court that plaintiffs firm Hagens Berman Sobol Shapiro LLP should bear the costs for the special master tasked with sorting out long-running disputes in a since-dropped product liability suit.

Motion attached | Read full article » | Save to favorites »

Teva Fights Class Cert. Bid In Effexor Antitrust Case

By George Woolston

Teva Pharmaceuticals urged a New Jersey federal judge Wednesday to reject a class certification bid by a group of direct buyers of the antidepressant drug Effexor XR and its generic versions, arguing that the proposed class failed to carry its burden showing that joinder is impracticable.

Read full article » | Save to favorites »

Fertility Clinic Says Doctors Lured Staff To New Practice

By Julie Manganis

The owners of a Massachusetts fertility clinic say three doctors left to start their own practice and repeatedly violated a non-solicitation agreement to "raid" its staff, according to a complaint filed in state court.

Complaint attached | Read full article » | Save to favorites »

Walgreens Says Audio Recording Refutes Shareholders' Claim

By Celeste Bott

Walgreens told an Illinois federal judge Tuesday that newly discovered evidence warrants revisiting a decision allowing shareholders' claim over an executive's allegedly false statement to move forward, saying an audio recording shows "no basis to conclude the actual statement was false or misleading when made."

Memorandum attached | Read full article » | Save to favorites »

Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger

By Al Barbarino

Regenerative medicine developer PrimeGen US said Wednesday it has agreed to go public through a merger with blank check company DT Cloud Star Acquisition Corp., in a deal that values the company at about $1.5 billion.

Read full article » | Save to favorites »

Ropes Leads Hair-Loss Firm Veradermics' Upsized $256M IPO

By Rae Ann Varona

Hair loss drug developer Veradermics Inc. began trading Wednesday after raising $256 million in an upsized initial public offering, with Ropes & Gray LLP representing the company and Cooley LLP representing the underwriters.

Read full article » | Save to favorites »

Ex-Hogan Lovells Regulatory Atty Moves To Honigman In DC

By James Boyle

An attorney specializing in guiding life sciences companies through the U.S. Food and Drug Administration's regulatory process has moved her practice to Honigman LLP's Washington, D.C., office after more than 11 years with Hogan Lovells.

Read full article » | Save to favorites »

New Biotech Nat'l Security Controls May Have Blunted Impact

While the newly enacted federal prohibition against contracting with certain biotechnology providers associated with countries of concern may have consequences on U.S. companies' ability to develop drugs, the restrictions may prove to be less problematic for the industry than the significant publicity around their passage would suggest, say attorneys at Wilson Sonsini.

Read full article » | Save to favorites »

From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination

With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.

Read full article » | Save to favorites »

Takeaways From The DOJ Fraud Section's 2025 Year In Review

Former acting Principal Deputy Chief Sean Tonolli of the U.S. Department of Justice's Fraud Section, now at Cahill Gordon, analyzes key findings from the section’s annual report — including the changes implemented to adapt to the new administration’s priorities — and lays out what to watch for this year.

Report attached | Read full article » | Save to favorites »

Series

Law School's Missed Lessons: Practicing Resilience

Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

Read full article » | Save to favorites »

CORRECTED: Ex-Worker Says Goldstein Offered Crypto, Gifts As IRS Probed

By Jared Foretek

A former employee at Thomas Goldstein's law firm who resigned after the Internal Revenue Service began investigating the firm said that the SCOTUSblog founder suddenly began offering her bitcoin, payment from case settlements and potential student loan relief after federal agents visited the office. Correction: An earlier version of this story, which was published January 29, mischaracterized the testimony of Special Agent Quoc Tuan Nguyen. Special Agent Nguyen addressed the dates in metadata that were altered in the course of the document production and did not allege Goldstein engaged in misconduct regarding the emails.

Read full article » | Save to favorites »

Alston & Bird Hires Ex-Baker McKenzie Tech, Privacy Pro

By Kevin Penton

Alston & Bird LLP has added a technology and privacy specialist previously with Baker McKenzie as a partner in its Silicon Valley office, the firm announced Thursday.

Read full article » | Save to favorites »

Judge Who Resigned To Criticize Trump Had Faced Inquiry

By Chris Villani

Former Massachusetts U.S. District Judge Mark L. Wolf was the subject of an inquiry into potential misconduct when he announced his November resignation, a decision he said at the time was motivated by a desire to speak out against the Trump administration, according to a source familiar with the matter.

2 documents attached | Read full article » | Save to favorites »

Cooley Adds Ex-Kirkland Corporate Real Estate Leader In NY

By Andrea Keckley

Cooley LLP announced it has hired the former leader of Kirkland & Ellis LLP's corporate real estate team.

Read full article » | Save to favorites »

Ga. Law Firm's CTA Challenge 'Hypothetical,' Feds Argue

By Chart Riggall

The U.S. Treasury Department has asked a federal judge to toss a Georgia lawyer's suit alleging that the 2021 Corporate Transparency Act could force him to violate attorney-client privilege, arguing the suit is based on future "hypothetical changes" to the federal policy of nonenforcement.

Motion attached | Read full article » | Save to favorites »

Judiciary Backs Bill To Let Judges Carry Concealed Guns

By Courtney Bublé

The federal judiciary has come out in support of a Republican-led bill to allow judges and prosecutors to carry concealed firearms across state lines, according to a letter obtained by Law360.

Letter attached | Read full article » | Save to favorites »

Judge Caps Off 'Beer Law' Trademark Case

By Elliot Weld

A federal judge has dismissed a trademark lawsuit from a North Carolina law firm that brands itself as the "Beer Law Center" against a Colorado firm that calls itself the "Beer Law HQ," finding the latter company lacked sufficient connections to North Carolina for the court to hear the case.

Order attached | Read full article » | Save to favorites »

NJ Atty Suspended For Faking Records, Lying To Client

By George Woolston

A New Jersey attorney has been suspended for six months for fabricating tax forms, billing records and contact information to support the existence of a fake secretary who he repeatedly attempted to blame for mishandling a client's lawsuit.

2 documents attached | Read full article » | Save to favorites »

Ex-Prosecutors Call For Independent Probes Of ICE Killings

By Rose Krebs

A coalition of former federal prosecutors and civil rights attorneys is urging U.S. Attorney General Pam Bondi to ensure that the U.S. Department of Justice allows for "transparent, unbiased and impartial" investigations into the killings in Minneapolis last month of Renee Good and Alex Pretti by federal immigration enforcement agents.

Read full article » | Save to favorites »

Meet New Paul Weiss Chairman Scott Barshay

By Anna Sanders

New Paul Weiss Rifkind Wharton & Garrison LLP chair Scott Barshay is a rainmaker who most recently led the corporate department, guiding clients through some of the largest transactions in recent history after joining the firm's New York office a decade ago.

Read full article » | Save to favorites »

Klobuchar Alarmed By Exodus Of Prosecutors In Minnesota

By Courtney Bublé

Sen. Amy Klobuchar, D-Minn., on Thursday said she was alarmed by the surge of resignations by federal prosecutors in her state following the shooting deaths of two Minnesotans by immigration agents.

Read full article » | Save to favorites »